Given the promising results of TDI in early detection, future studies could explore the potential impact of heart failure medications, such as ACE inhibitors (ACEi) or beta-blockers, on improving TDI parameters and overall cardiac function in patients receiving Adriamycin. This evidence concerns the gene ACE and heart failure.